Vident Investment Advisory’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-5,483
| Closed | -$85K | – | 1166 |
|
|
2021
Q2 | $85K | Hold |
5,483
| – | – | ﹤0.01% | 1086 |
|
|
2021
Q1 | $132K | Sell |
5,483
-3,550
| -39% | -$85.5K | ﹤0.01% | 979 |
|
|
2020
Q4 | $266K | Sell |
9,033
-37
| -0.4% | -$1.09K | 0.01% | 834 |
|
|
2020
Q3 | $139K | Buy |
9,070
+2,316
| +34% | +$35.5K | 0.01% | 848 |
|
|
2020
Q2 | $169K | Sell |
6,754
-1,803
| -21% | -$45.1K | 0.01% | 816 |
|
|
2020
Q1 | $175K | Buy |
8,557
+1,716
| +25% | +$35.1K | 0.01% | 756 |
|
|
2019
Q4 | $211K | Buy |
6,841
+1,999
| +41% | +$61.7K | 0.01% | 658 |
|
|
2019
Q3 | $162K | Buy |
4,842
+2,577
| +114% | +$86.2K | 0.01% | 447 |
|
|
2019
Q2 | $72K | Hold |
2,265
| – | – | 0.01% | 435 |
|
|
2019
Q1 | $65K | Buy |
+2,265
| New | +$65K | ﹤0.01% | 695 |
|